Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Cold-Steel Phonosurgery of Reinke Edema Evaluated by the Multidimensional Voice Program

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Individual values of antineutrophil cytoplasmic antibodies do not correspond between antigen-specific assays

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  3. Vaskulit

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiForskningpeer review

  4. Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Jan Damoiseaux
  • Elena Csernok
  • Niels Rasmussen
  • Frank Moosig
  • Pieter van Paassen
  • Bo Baslund
  • Pieter Vermeersch
  • Daniel Blockmans
  • Jan-Willem Cohen Tervaert
  • Xavier Bossuyt
Vis graf over relationer

OBJECTIVE: This multicentre study was performed to evaluate the diagnostic accuracy of a wide spectrum of novel technologies nowadays available for detection of myeloperoxidase (MPO) and proteinase 3 (PR3)-antineutrophil cytoplasmic antibodies (ANCAs).

METHODS: Sera (obtained at the time of diagnosis) from 251 patients with ANCA-associated vasculitis (AAV), including granulomatosis with polyangiitis and microscopic polyangiitis, and from 924 disease controls were tested for the presence of cytoplasmic pattern/perinuclear pattern and atypical ANCA (A-ANCA) by indirect immunofluorescence (IIF) (at two sites) and for the presence of PR3-ANCA and MPO-ANCA by eight different immunoassays.

RESULTS: The area under the curve (AUC) of the receiver operating characteristic curve to discriminate AAV from controls was 0.923 (95% CI 0.902 to 0.944) and 0.843 (95% CI 0.814 to 0.871) for the two IIF methods. For the antigen-specific immunoassays, the AUC varied between 0.936 (95% CI 0.912 to 0.960) and 0.959 (95% CI 0.941 to 0.976), except for one immunoassay for which the AUC was 0.919 (95% CI 0.892 to 0.945).

CONCLUSIONS: Our comparison of various ANCA detection methods showed (i) large variability between the two IIF methods tested and (ii) a high diagnostic performance of PR3-ANCA and MPO-ANCA by immunoassay to discriminate AAV from disease controls. Consequently, dual IIF/antigen-specific immunoassay testing of each sample is not necessary for maximal diagnostic accuracy. These results indicate that the current international consensus on ANCA testing for AAV needs revision.

OriginalsprogEngelsk
TidsskriftAnnals of the Rheumatic Diseases
Vol/bind76
Udgave nummer4
Sider (fra-til)647-653
Antal sider7
ISSN0003-4967
DOI
StatusUdgivet - apr. 2017

ID: 49913880